Definitive Contract 75N93018C00051
Award Date
8/28/18
Potential Completion Date
11/30/20
Potential Value
$1.5M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Luna Innovations Incorporated
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Roanoke, VA 24011, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The contract, valued at $1,499,998.00, is for the development of innovative pediatric oral formulations for second-line tuberculosis drugs. This contract is set aside for small businesses. Luna Labs USA LLC, a leading provider of advanced...
The U.S. Department of Health and Human Services (HHS) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $224,997.00 Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated for the development of a "Ligand Magneto Kit for Fast Modular Bacteria Collection." This definitive, firm fixed-price contract will be performed in Danville, Virginia and is scheduled for completion by July 31, 2016. Luna Innovations is a leading provider...
This is a Small Business Innovation Research (SBIR) contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Luna Labs USA LLC, a subsidiary of Luna Innovations Incorporated. The $599,993.00 firm fixed-price contract is for developing "Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models." This SBIR contract is set aside for small businesses and supports NIAID's mission...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The $299,997.00 Firm Fixed Price contract is for the development of a long-acting antiviral implant for the treatment of hepatitis C virus (HCV). The contract has a total completion date of August 31, 2025. Luna Labs USA LLC is the prime contractor on this small...
This is a $299,998.00 definitive contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a for-profit manufacturer of goods. The contract is for a firm fixed price and does not have a set-aside designation. Based on Luna Innovations' background, the contract likely involves the provision of specialized optical and sensing instruments, fiber optic technologies, and...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Program Phase I contract to Northbound Therapeutics, Inc., a minority-owned, woman-owned small business, to develop an inhaled clofazimine powder as a novel treatment for multidrug-resistant tuberculosis (MDR-TB). The contract, valued at $37,500, is for the formulation and preclinical evaluation of the inhaled clofazimine powder. This SBIR contract is a Firm Fixed Price...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Luna Innovations Incorporated. The objective of this $299,956 Firm Fixed Price contract is to develop a novel layer-by-layer (LBL) RNA vaccine that can provide long-lasting protection against HIV. Luna Innovations is a small business that specializes in fiber optic sensing and measurement systems, and has previously...
This is a $224,953.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Innovations Incorporated, a small business manufacturer, under the SBIR program. The contract is for the development and delivery of a "Magnetic Microparticle Kit for Cell Removal from Blood" and has a period of performance ending on August 17, 2016. This contract is for Phase I research and development under the SBIR program, which supports small...
This is a $1,486,937 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to PAI Life Sciences Inc., a self-certified small disadvantaged business. The contract is for the development of an inhaled drug combination for tuberculosis therapy under the SBIR Phase II program. Key tasks include the manufacture of spray-dried combination drugs, technical support for pharmacokinetic and...